COMBINATION METOCLOPRAMIDE AND DIPHENHYDRAMINE SHORT INFUSION FOR PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS

被引：2
作者：
PRZEPIORKA, D
KATLUBECK, A
TAYLOR, D
机构：
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1990年 / 13卷 / 02期
关键词：
D O I：
10.1097/00000421-199004000-00019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：180 / 180
页数：1
相关论文
共 3 条
[1]   ANTIEMETIC ACTIVITY OF HIGH-DOSE METOCLOPRAMIDE COMBINED WITH METHYLPREDNISOLONE VERSUS METOCLOPRAMIDE ALONE IN DACARBAZINE-TREATED CANCER-PATIENTS - A RANDOMIZED DOUBLE-BLIND-STUDY OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH [J].
BASURTO, C ;
ROILA, F ;
TONATO, M ;
BALLATORI, E ;
BUZZI, F ;
CALABRESI, F ;
DELFAVERO, A .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (03) :235-238
[2]   ORAL METOCLOPRAMIDE WITH OR WITHOUT DIPHENHYDRAMINE - POTENTIAL FOR PREVENTION OF LATE NAUSEA AND VOMITING INDUCED BY CISPLATIN [J].
GRUNBERG, SM ;
EHLER, E ;
MCDERMED, JE ;
AKERLEY, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (11) :864-868
[3]  
KRIS MG, 1983, NEW ENGL J MED, V309, P433
1